The global hemostats market, valued at $2.6 billion in 2022, is projected to achieve significant growth, reaching $4.11 billion by 2030. This expansion is expected to occur at a compound annual growth rate (CAGR) of 5.9% during the forecast period from 2023 to 2030. Key Players The major players are C.R Bard, Baxter, Teleflex Incorporated, Ethicon, Medtronic Plc,...